The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Early Detection Market Research Report 2025
Synopsis
The 2 components of early detection of cancer are early diagnosis (or downstaging) and screening. Early diagnosis focuses on detecting symptomatic patients as early as possible, while screening consists of testing healthy individuals to identify those having cancers before any symptoms appear.
The global Cancer Early Detection market was valued at US$ 215 million in 2023 and is anticipated to reach US$ 367.8 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The market for cancer early detection is rapidly expanding, driven by continuous innovation and advancements in medical technology, leading to a gradual increase in market size. Sales are consistently on the rise, primarily catering to early screening and diagnosis of various cancers such as lung, breast, and colorectal cancer. Future development trends are poised to concentrate on more precise biomarker detection, efficient imaging diagnostic techniques, and intelligent medical assistive tools, aiming to enhance the accuracy and convenience of cancer early detection, ultimately reducing cancer incidence rates effectively and improving the chances of successful treatment.
This report aims to provide a comprehensive presentation of the global market for Cancer Early Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Early Detection.
Report Scope
The Cancer Early Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Early Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Early Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Segment by Type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Segment by Application
Hospital
Medical Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Early Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The 2 components of early detection of cancer are early diagnosis (or downstaging) and screening. Early diagnosis focuses on detecting symptomatic patients as early as possible, while screening consists of testing healthy individuals to identify those having cancers before any symptoms appear.
The global Cancer Early Detection market was valued at US$ 215 million in 2023 and is anticipated to reach US$ 367.8 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The market for cancer early detection is rapidly expanding, driven by continuous innovation and advancements in medical technology, leading to a gradual increase in market size. Sales are consistently on the rise, primarily catering to early screening and diagnosis of various cancers such as lung, breast, and colorectal cancer. Future development trends are poised to concentrate on more precise biomarker detection, efficient imaging diagnostic techniques, and intelligent medical assistive tools, aiming to enhance the accuracy and convenience of cancer early detection, ultimately reducing cancer incidence rates effectively and improving the chances of successful treatment.
This report aims to provide a comprehensive presentation of the global market for Cancer Early Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Early Detection.
Report Scope
The Cancer Early Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Early Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Early Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Segment by Type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Segment by Application
Hospital
Medical Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Early Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Early Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Early Detection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Early Detection Market Perspective (2019-2030)
2.2 Cancer Early Detection Growth Trends by Region
2.2.1 Global Cancer Early Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Early Detection Historic Market Size by Region (2019-2024)
2.2.3 Cancer Early Detection Forecasted Market Size by Region (2025-2030)
2.3 Cancer Early Detection Market Dynamics
2.3.1 Cancer Early Detection Industry Trends
2.3.2 Cancer Early Detection Market Drivers
2.3.3 Cancer Early Detection Market Challenges
2.3.4 Cancer Early Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Early Detection Players by Revenue
3.1.1 Global Top Cancer Early Detection Players by Revenue (2019-2024)
3.1.2 Global Cancer Early Detection Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Early Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Early Detection Revenue
3.4 Global Cancer Early Detection Market Concentration Ratio
3.4.1 Global Cancer Early Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Early Detection Revenue in 2023
3.5 Cancer Early Detection Key Players Head office and Area Served
3.6 Key Players Cancer Early Detection Product Solution and Service
3.7 Date of Enter into Cancer Early Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Early Detection Breakdown Data by Type
4.1 Global Cancer Early Detection Historic Market Size by Type (2019-2024)
4.2 Global Cancer Early Detection Forecasted Market Size by Type (2025-2030)
5 Cancer Early Detection Breakdown Data by Application
5.1 Global Cancer Early Detection Historic Market Size by Application (2019-2024)
5.2 Global Cancer Early Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Early Detection Market Size (2019-2030)
6.2 North America Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Early Detection Market Size by Country (2019-2024)
6.4 North America Cancer Early Detection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Early Detection Market Size (2019-2030)
7.2 Europe Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Early Detection Market Size by Country (2019-2024)
7.4 Europe Cancer Early Detection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Early Detection Market Size (2019-2030)
8.2 Asia-Pacific Cancer Early Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Early Detection Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Early Detection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Early Detection Market Size (2019-2030)
9.2 Latin America Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Early Detection Market Size by Country (2019-2024)
9.4 Latin America Cancer Early Detection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Early Detection Market Size (2019-2030)
10.2 Middle East & Africa Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Early Detection Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Early Detection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exact Sciences
11.1.1 Exact Sciences Company Detail
11.1.2 Exact Sciences Business Overview
11.1.3 Exact Sciences Cancer Early Detection Introduction
11.1.4 Exact Sciences Revenue in Cancer Early Detection Business (2019-2024)
11.1.5 Exact Sciences Recent Development
11.2 Grail
11.2.1 Grail Company Detail
11.2.2 Grail Business Overview
11.2.3 Grail Cancer Early Detection Introduction
11.2.4 Grail Revenue in Cancer Early Detection Business (2019-2024)
11.2.5 Grail Recent Development
11.3 Genetron Health
11.3.1 Genetron Health Company Detail
11.3.2 Genetron Health Business Overview
11.3.3 Genetron Health Cancer Early Detection Introduction
11.3.4 Genetron Health Revenue in Cancer Early Detection Business (2019-2024)
11.3.5 Genetron Health Recent Development
11.4 New Horizon Health
11.4.1 New Horizon Health Company Detail
11.4.2 New Horizon Health Business Overview
11.4.3 New Horizon Health Cancer Early Detection Introduction
11.4.4 New Horizon Health Revenue in Cancer Early Detection Business (2019-2024)
11.4.5 New Horizon Health Recent Development
11.5 Burning Rock
11.5.1 Burning Rock Company Detail
11.5.2 Burning Rock Business Overview
11.5.3 Burning Rock Cancer Early Detection Introduction
11.5.4 Burning Rock Revenue in Cancer Early Detection Business (2019-2024)
11.5.5 Burning Rock Recent Development
11.6 Berry Oncology
11.6.1 Berry Oncology Company Detail
11.6.2 Berry Oncology Business Overview
11.6.3 Berry Oncology Cancer Early Detection Introduction
11.6.4 Berry Oncology Revenue in Cancer Early Detection Business (2019-2024)
11.6.5 Berry Oncology Recent Development
11.7 Shanghai Kunyuan Biotechnology
11.7.1 Shanghai Kunyuan Biotechnology Company Detail
11.7.2 Shanghai Kunyuan Biotechnology Business Overview
11.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection Introduction
11.7.4 Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection Business (2019-2024)
11.7.5 Shanghai Kunyuan Biotechnology Recent Development
11.8 Oncognostic
11.8.1 Oncognostic Company Detail
11.8.2 Oncognostic Business Overview
11.8.3 Oncognostic Cancer Early Detection Introduction
11.8.4 Oncognostic Revenue in Cancer Early Detection Business (2019-2024)
11.8.5 Oncognostic Recent Development
11.9 Epigenomics
11.9.1 Epigenomics Company Detail
11.9.2 Epigenomics Business Overview
11.9.3 Epigenomics Cancer Early Detection Introduction
11.9.4 Epigenomics Revenue in Cancer Early Detection Business (2019-2024)
11.9.5 Epigenomics Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott Cancer Early Detection Introduction
11.10.4 Abbott Revenue in Cancer Early Detection Business (2019-2024)
11.10.5 Abbott Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Detail
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Cancer Early Detection Introduction
11.11.4 Qiagen Revenue in Cancer Early Detection Business (2019-2024)
11.11.5 Qiagen Recent Development
11.12 iStat Biomedical
11.12.1 iStat Biomedical Company Detail
11.12.2 iStat Biomedical Business Overview
11.12.3 iStat Biomedical Cancer Early Detection Introduction
11.12.4 iStat Biomedical Revenue in Cancer Early Detection Business (2019-2024)
11.12.5 iStat Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cancer Early Detection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Colorectal Cancer
Table 3. Key Players of Liver Cancer
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other
Table 6. Global Cancer Early Detection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cancer Early Detection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Cancer Early Detection Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Cancer Early Detection Market Share by Region (2019-2024)
Table 10. Global Cancer Early Detection Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Cancer Early Detection Market Share by Region (2025-2030)
Table 12. Cancer Early Detection Market Trends
Table 13. Cancer Early Detection Market Drivers
Table 14. Cancer Early Detection Market Challenges
Table 15. Cancer Early Detection Market Restraints
Table 16. Global Cancer Early Detection Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Cancer Early Detection Market Share by Players (2019-2024)
Table 18. Global Top Cancer Early Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection as of 2023)
Table 19. Ranking of Global Top Cancer Early Detection Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Cancer Early Detection Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Early Detection Product Solution and Service
Table 23. Date of Enter into Cancer Early Detection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Early Detection Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Cancer Early Detection Revenue Market Share by Type (2019-2024)
Table 27. Global Cancer Early Detection Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Cancer Early Detection Revenue Market Share by Type (2025-2030)
Table 29. Global Cancer Early Detection Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Cancer Early Detection Revenue Market Share by Application (2019-2024)
Table 31. Global Cancer Early Detection Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Cancer Early Detection Revenue Market Share by Application (2025-2030)
Table 33. North America Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Cancer Early Detection Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Cancer Early Detection Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Cancer Early Detection Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)
Table 48. Exact Sciences Company Detail
Table 49. Exact Sciences Business Overview
Table 50. Exact Sciences Cancer Early Detection Product
Table 51. Exact Sciences Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 52. Exact Sciences Recent Development
Table 53. Grail Company Detail
Table 54. Grail Business Overview
Table 55. Grail Cancer Early Detection Product
Table 56. Grail Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 57. Grail Recent Development
Table 58. Genetron Health Company Detail
Table 59. Genetron Health Business Overview
Table 60. Genetron Health Cancer Early Detection Product
Table 61. Genetron Health Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 62. Genetron Health Recent Development
Table 63. New Horizon Health Company Detail
Table 64. New Horizon Health Business Overview
Table 65. New Horizon Health Cancer Early Detection Product
Table 66. New Horizon Health Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 67. New Horizon Health Recent Development
Table 68. Burning Rock Company Detail
Table 69. Burning Rock Business Overview
Table 70. Burning Rock Cancer Early Detection Product
Table 71. Burning Rock Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 72. Burning Rock Recent Development
Table 73. Berry Oncology Company Detail
Table 74. Berry Oncology Business Overview
Table 75. Berry Oncology Cancer Early Detection Product
Table 76. Berry Oncology Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 77. Berry Oncology Recent Development
Table 78. Shanghai Kunyuan Biotechnology Company Detail
Table 79. Shanghai Kunyuan Biotechnology Business Overview
Table 80. Shanghai Kunyuan Biotechnology Cancer Early Detection Product
Table 81. Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 82. Shanghai Kunyuan Biotechnology Recent Development
Table 83. Oncognostic Company Detail
Table 84. Oncognostic Business Overview
Table 85. Oncognostic Cancer Early Detection Product
Table 86. Oncognostic Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 87. Oncognostic Recent Development
Table 88. Epigenomics Company Detail
Table 89. Epigenomics Business Overview
Table 90. Epigenomics Cancer Early Detection Product
Table 91. Epigenomics Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 92. Epigenomics Recent Development
Table 93. Abbott Company Detail
Table 94. Abbott Business Overview
Table 95. Abbott Cancer Early Detection Product
Table 96. Abbott Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 97. Abbott Recent Development
Table 98. Qiagen Company Detail
Table 99. Qiagen Business Overview
Table 100. Qiagen Cancer Early Detection Product
Table 101. Qiagen Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 102. Qiagen Recent Development
Table 103. iStat Biomedical Company Detail
Table 104. iStat Biomedical Business Overview
Table 105. iStat Biomedical Cancer Early Detection Product
Table 106. iStat Biomedical Revenue in Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 107. iStat Biomedical Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Early Detection Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Early Detection Market Share by Type: 2023 VS 2030
Figure 3. Colorectal Cancer Features
Figure 4. Liver Cancer Features
Figure 5. Lung Cancer Features
Figure 6. Other Features
Figure 7. Global Cancer Early Detection Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Cancer Early Detection Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Medical Center Case Studies
Figure 11. Other Case Studies
Figure 12. Cancer Early Detection Report Years Considered
Figure 13. Global Cancer Early Detection Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cancer Early Detection Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cancer Early Detection Market Share by Region: 2023 VS 2030
Figure 16. Global Cancer Early Detection Market Share by Players in 2023
Figure 17. Global Top Cancer Early Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cancer Early Detection Revenue in 2023
Figure 19. North America Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cancer Early Detection Market Share by Country (2019-2030)
Figure 21. United States Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cancer Early Detection Market Share by Country (2019-2030)
Figure 25. Germany Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cancer Early Detection Market Share by Region (2019-2030)
Figure 33. China Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cancer Early Detection Market Share by Country (2019-2030)
Figure 41. Mexico Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cancer Early Detection Market Share by Country (2019-2030)
Figure 45. Turkey Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Exact Sciences Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 48. Grail Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 49. Genetron Health Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 50. New Horizon Health Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 51. Burning Rock Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 52. Berry Oncology Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 53. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 54. Oncognostic Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 55. Epigenomics Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 56. Abbott Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 57. Qiagen Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 58. iStat Biomedical Revenue Growth Rate in Cancer Early Detection Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
